Related Experiment Video
Updated: Aug 11, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Current status of DNA diagnosis for hereditary nephropathies
K Zerres1, S Rudnik-Schöneborn
1Institut für Humangenetik, Universität Bonn, Germany.
Abstract:
The molecular genetic defect of many hereditary nephropathies has been assigned to a specific chromosomal region or has even been identified. While the localization of a gene permits an indirect genotype analysis to estimate the risk status of a close relative of a patient with a proven clinical diagnosis, it is not possible to confirm a diagnosis in case of inconclusive clinical data. In some nephropathies, the gene has been cloned and mutations identified. By demonstrating the molecular genetic defect in these patients, the diagnosis can be ensured and an easily assessible method of carrier detection can be offered. The possibilities and limitations of DNA diagnosis in some important nephropathies are outlined.
Related Concept Videos
Karyotyping
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Diabetic Nephropathy

